---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-035162"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T06:13:21.785526+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AgeX stockholders approve doubling authorized shares to 200M and adding 4M shares to equity plan

## Summary
- Elected directors Bailey, Hackett, May, West with ~20.4M-20.7M votes each; 5.2M broker non-votes.
- Ratified WithumSmith+Brown as auditor for FY2022: 26.8M for, 31K against.
- Approved amendment to increase authorized common stock from 100M to 200M shares (20.8M for, 1.3M against).
- Approved 2017 Equity Incentive Plan amendment adding 4M shares, total now 8.5M shares available (20.1M for).
- Approved Juvenescence proposal to acquire >19.9% or 50%+ of AGE shares via warrants/loan conversion (20.4M for).

## SEC filing metadata
- accession: 0001493152-22-035162
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-035162
- JSON: https://secwatch.observer/filing/0001493152-22-035162.json
- Plain text: https://secwatch.observer/filing/0001493152-22-035162.txt

## Key facts
- Shareholder Votes
  Serina Therapeutics, Inc. shareholders approved Common Stock Amendment Proposal - amendment to Certificate of Incorporation to increase authorized shares from 100,000,000 to 200,000,000 at the 2022-12-07 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Common Stock Amendment Proposal The Common Stock Amendment Proposal was approved by the following vote: Shares Voted For 20,798,910 Against 1,341,037 Abstain 22,781 In addition, there were 4,736,638 broker non-votes on this matter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
- Shareholder Votes
  Serina Therapeutics, Inc. shareholders approved Incentive Plan Amendment Proposal - amendment of 2017 Equity Incentive Plan to make additional 4,000,000 shares available at the 2022-12-07 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Incentive Plan Amendment Proposal The Incentive Plan Amendment Proposal was approved by the following vote: Shares Voted For 20,127,120 Against 1,474,349 Abstain 53,488 In addition, there were 5,244,408 broker non-votes on this matter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
- Shareholder Votes
  Serina Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accountants at the 2022-12-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Ratification of Appointment of Independent Registered Public Accountants The appointment of WithumSmith + Brown PC as our independent registered public accountants for the fiscal year ending December 31, 2022 was ratified by the following vote: Shares Voted For 26,776,985 Against 31,458 Abstain 90,923 There were no broker non-votes on this matter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
- Shareholder Votes
  Serina Therapeutics, Inc. shareholders approved Election of Directors at the 2022-12-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Election of Directors Each of the following nominees were elected as directors by the following vote: Nominee Votes For Votes Withheld Gregory Bailey 20,443,999 1,210,959 Joanne Hackett 20,457,478 1,197,480 Michael May 20,469,901 1,185,057 Michael D. West 20,685,723 969,235 In addition, there were 5,244,408 broker non-votes with respect to the election of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
- Shareholder Votes
  Serina Therapeutics, Inc. shareholders approved Juvenescence Proposal - to permit Juvenescence Limited to acquire additional shares of AgeX common stock through exercise of warrants or conversion of loans at the 2022-12-07 meeting.
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Juvenescence Proposal The Juvenescence was approved by the following vote: Shares Voted For 20,393,670 Against 1,204,612 Abstain 56,676 In addition, there were 5,244,408 broker non-votes on this matter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.